Publication related to RSI or an RSI staff member

A validation sampling approach for consistent estimation of adverse drug reaction risk with misclassified right-censored survival data.

Authors

  • Gravel, Christopher A, Gravel CA, School of Mathematics and Statistics, Carleton University, Ottawa, Ontario, Canada.; Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Ontario, Canada.

  • Dewanji, Anup, Dewanji A, Applied Statistics Unit, Indian Statistical Institute, Kolkata, India.

  • Farrell, Patrick J, Farrell PJ, School of Mathematics and Statistics, Carleton University, Ottawa, Ontario, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.

  • Krewski, Daniel, Krewski D, School of Mathematics and Statistics, Carleton University, Ottawa, Ontario, Canada.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.; Department of Mathematics and Statistics, University of Ottawa, Ottawa, Ontario, Canada.; Risk Sciences International, Ottawa, Ontario, Canada.

YEAR OF PUBLICATION: 2018
SOURCE: Stat Med. 2018 Nov 30;37(27):3887-3903. doi: 10.1002/sim.7854. Epub 2018 Aug 6.
JOURNAL TITLE ABBREVIATION: Stat Med
JOURNAL TITLE: Statistics in medicine
ISSN: 1097-0258 (Electronic) 0277-6715 (Linking)
VOLUME: 37
ISSUE: 27
PAGES: 3887-3903
PLACE OF PUBLICATION: England
ABSTRACT:
Patient electronic health records, viewed as continuous-time right-censored survival data, can be used to estimate adverse drug reaction risk. Temporal outcome misclassification may occur as a result of errors in follow-up. These errors can be due to a failure to observe the incidence time of the adverse event of interest (due to misdiagnosis or nonreporting, etc) or an actual misdiagnosis of a competing adverse event. As the misclassifying event is often unobservable in the original data, we apply an internal validation sampling approach to produce consistent estimation in the presence of such errors. We introduce a univariate survival model and a cause-specific hazards model in which misclassification may also manifest as a diagnosis of an alternate adverse health outcome other than that of interest. We develop a method of maximum likelihood estimation of the model parameters and establish consistency and asymptotic normality of the estimators using standard results. We also conduct simulation studies to numerically investigate the finite sample properties of these estimators and the impact of ignoring the misclassification error.
COPYRIGHT INFORMATION: (c) 2018 John Wiley & Sons, Ltd.
LANGUAGE: eng
DATE OF PUBLICATION: 2018 Nov 30
DATE OF ELECTRONIC PUBLICATION: 20180806
DATE COMPLETED: 20191121
DATE REVISED: 20191121
MESH DATE: 2019/11/22 06:00
EDAT: 2018/08/08 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1002/sim.7854 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski